Ecog-acrin Cancer Research Group
Clinical trials sponsored by Ecog-acrin Cancer Research Group, explained in plain language.
-
Drug combo tested to shrink tumors before melanoma surgery
Disease control TerminatedThis study tested whether giving two targeted drugs (encorafenib and binimetinib) before surgery could help shrink melanoma tumors in patients whose cancer had spread to nearby lymph nodes. The drugs aim to block signals that help cancer cells grow. The trial also tested whether …
Phase: PHASE2 • Sponsor: ECOG-ACRIN Cancer Research Group • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
Can a malaria drug help beat tough skin cancer?
Disease control TerminatedThis study tested whether adding the drug hydroxychloroquine to a standard two-drug treatment (dabrafenib and trametinib) could better control advanced melanoma that has a specific BRAF gene mutation. It aimed to see if the three-drug combo could delay cancer growth longer than t…
Phase: PHASE2 • Sponsor: ECOG-ACRIN Cancer Research Group • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
Race to tame deadly side effect of promising cancer drugs
Disease control TerminatedThis study aimed to find a better treatment for a serious lung inflammation that can occur as a side effect of certain cancer immunotherapies when standard steroid treatment fails. It tested two different drug combinations (infliximab or intravenous immunoglobulin) in cancer pati…
Phase: PHASE2 • Sponsor: ECOG-ACRIN Cancer Research Group • Aim: Disease control
Last updated Mar 20, 2026 14:47 UTC